Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,878
Closed -$307K 57
2025
Q2
$307K Buy
3,878
+61
+2% +$4.85K 0.2% 42
2025
Q1
$343K Sell
3,817
-106
-3% -$9.9K 0.24% 39
2024
Q4
$390K Hold
3,923
0.27% 35
2024
Q3
$445K Buy
3,923
+3
+0.1% +$356 0.31% 31
2024
Q2
$485K Sell
3,920
-470
-11% -$60.5K 0.37% 27
2024
Q1
$579K Sell
4,390
-163
-4% -$20.1K 0.46% 25
2023
Q4
$496K Hold
4,553
0.41% 28
2023
Q3
$468K Buy
4,553
+179
+4% +$19.3K 0.45% 29
2023
Q2
$500K Buy
+4,374
New +$497K 0.46% 28

Other funds holding MRK

Michael S. Ryan Inc's MRK Position: Q3 2025 in Review

Michael S. Ryan Inc sold out of Merck (MRK) in Q3 2025, closing a stake of 3,878 shares — an estimated $307K sold.

Michael S. Ryan Inc first reported a position in MRK in Q2 2023 and held it in 9 quarters. The position peaked at $579K in Q1 2024. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Michael S. Ryan Inc reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Michael S. Ryan Inc sold 3,878 Merck shares in Q3 2025, an estimated $307K.
  • Michael S. Ryan Inc first reported a position in Merck in Q2 2023 and held it in 9 quarters.
  • Michael S. Ryan Inc's Merck position peaked at $579K in Q1 2024.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Michael S. Ryan Inc's 13F filing for Q3 2025, filed 15 Oct 2025.